|
HY-W088089-25mg
|
MedChemexpress LLC
|
ICG-carboxylic acid [CAS 181934-09-8]
|
|
|
|
|
HY-W088089-50mg
|
MedChemexpress LLC
|
ICG-carboxylic acid [CAS 181934-09-8]
|
|
|
|
|
HY-17514-100mg
|
MedChemexpress LLC
|
Itraconazole [CAS 84625-61-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-17514-500mg
|
MedChemexpress LLC
|
Itraconazole [CAS 84625-61-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-17514S-1mg
|
MedChemexpress LLC
|
Itraconazole-d5 [CAS 1217510-38-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-17514S2-1mg
|
MedChemexpress LLC
|
Itraconazole-d9 [CAS 1309272-50-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-10209A-10mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-100mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-200mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-5mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-50mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-1mL
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-10209-10mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209-100mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209-200mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209-5mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209-50mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209-1mL
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
sc-212776
|
Santa Cruz Biotechnology
|
Rhodamine 800 [CAS 101027-54-7]
|
|
|
|
